Index
RUT
Market Cap
2.29B
Enterprise Value
2.68B
Income
151.70M
Sales
668.47M
Book/sh
14.96
Cash/sh
13.63
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
898
IPO
May 02, 2019
P/E
17.17
Forward P/E
29.19
PEG
-
P/S
3.42
P/B
4.41
P/C
4.84
P/FCF
28.95
EV/EBITDA
22.73
EV/Sales
4.01
Quick Ratio
6.07
Current Ratio
6.62
Debt/Eq
1.67
LT Debt/Eq
1.63
Option/Short
Yes / Yes
EPS (ttm)
3.84
EPS next Y
2.26
EPS next Q
0.30
EPS this Y
-69.91%
EPS next Y
54.25%
EPS next 5Y
-13.19%
EPS past 3/5Y
- -
Sales past 3/5Y
86.42% 88.21%
EPS Y/Y TTM
108.84%
Sales Y/Y TTM
25.82%
EPS Q/Q
-55.84%
Sales Q/Q
20.70%
Insider Own
3.86%
Insider Trans
-0.62%
Inst Own
105.36%
Inst Trans
-5.02%
ROA
12.88%
ROE
36.28%
ROIC
11.14%
Gross Margin
57.75%
Oper. Margin
12.21%
Profit Margin
22.69%
SMA20
-11.02%
SMA50
-19.18%
SMA200
-30.16%
Trades
Shs Outstand
34.63M
Shs Float
33.34M
52W High
156.00 -57.70%
52W Low
60.10 9.79%
Volatility
4.14% 4.97%
ATR (14)
3.64
RSI (14)
28.92
Beta
2.09
Rel Volume
1.08
Avg Volume
832.64K
Volume
900,114
Perf Week
-6.71%
Perf Month
-16.09%
Perf Quarter
-19.08%
Perf Half Y
-34.02%
Perf YTD
-45.75%
Perf Year
-51.40%
Perf 3Y
79.61%
Perf 5Y
140.58%
Perf 10Y
-
Prev Close
67.12
Price
65.99
Change %
-1.68%
Analysts 12 incl. previous ratings
Rating Distribution 8 Buy · 4 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Oct 07, 2026 Initiated B Barclays
Overweight $120 +81.8% Jul 28, 2026 Initiated U UBS
Neutral $80 +21.2% May 06, 2026 Downgrade O Oppenheimer
Outperform → Perform Oct 23, 2025 Upgrade N Needham
Hold → Buy $148 +124.3% Oct 13, 2025 Initiated J Jefferies
Buy $145 +119.7% Sep 16, 2025 Initiated E Evercore ISI
Outperform $155 +134.9% Sep 04, 2025 Initiated S Stifel
Hold $115 +74.3% Dec 17, 2024 Downgrade J JP Morgan
Overweight → Neutral $116 → $75 +13.7% Nov 22, 2024 Downgrade N Needham
Buy → Hold Oct 29, 2024 Reiterated O Oppenheimer
Outperform $200 → $125 +89.4% Oct 29, 2024 Reiterated N Needham
Buy $208 → $109 +65.2% Sep 24, 2024 Initiated R Robert W. Baird
Outperform $200 +203.1% Aug 21, 2024 Initiated N Needham
Buy $208 +215.2% Jun 06, 2024 Initiated C Cantor Fitzgerald
Overweight $161 +144.0% Jun 04, 2024 Initiated S Stephens
Overweight $151 +128.8% Mar 28, 2024 Initiated P Piper Sandler
Overweight $95 +44.0% Jul 19, 2023 Initiated R Robert W. Baird
Outperform Aug 02, 2022 Upgrade J JP Morgan
Neutral → Overweight $48 -27.3% Oct 08, 2020 Downgrade J JP Morgan
Overweight → Neutral $15 -77.3% Apr 07, 2020 Initiated O Oppenheimer
Outperform $25 -62.1%
Show Previous Ratings
Oct-30-26 04:05PM
Oct-29-26 05:01PM
Oct-28-26 09:37PM
Oct-22-26 04:05PM
Oct-07-26 10:00AM
01:44AM
Loading…
Sep-26-26 01:44AM
Sep-10-26 04:05PM
Aug-31-26 04:05PM
Aug-17-26 03:00AM
Aug-05-26 01:07AM
Aug-04-26 04:21PM
04:05PM
Aug-03-26 04:05PM
Jul-28-26 04:29PM
Jul-24-26 02:25PM
04:05PM
Loading…
Jul-21-26 04:05PM
Jul-06-26 07:05AM
Jul-01-26 07:54PM
May-21-26 04:05PM
May-19-26 04:05PM
May-08-26 11:00AM
May-07-26 03:50PM
May-06-26 09:38AM
May-05-26 04:28PM
04:05PM
Apr-29-26 09:26AM
Apr-23-26 07:00AM
Apr-21-26 04:05PM
Mar-19-26 09:00AM
Mar-05-26 02:01PM
(Investor's Business Daily)
-5.14%
07:00AM
Loading…
Feb-27-26 07:00AM
Feb-25-26 11:50AM
10:17AM
01:07AM
12:03AM
Feb-24-26 08:00PM
07:30PM
04:45PM
(Associated Press Finance)
04:05PM
Feb-23-26 10:33AM
09:15AM
Feb-20-26 04:05PM
Feb-17-26 05:25PM
04:05PM
Feb-16-26 10:52AM
Feb-13-26 03:32PM
Feb-12-26 05:15PM
Feb-10-26 04:05PM
Feb-09-26 08:00AM
Feb-03-26 09:34PM
Feb-02-26 02:08PM
Jan-29-26 06:20AM
Jan-28-26 01:22PM
(Investor's Business Daily)
Jan-14-26 10:48AM
Jan-12-26 08:10AM
Jan-11-26 11:24PM
Jan-09-26 09:18AM
Dec-30-25 04:05PM
Dec-29-25 10:50AM
Dec-27-25 01:35PM
Dec-26-25 09:45AM
Dec-24-25 04:05PM
Dec-23-25 06:30AM
Dec-18-25 09:08AM
Dec-16-25 09:50AM
Dec-10-25 08:05AM
Dec-09-25 05:05PM
Dec-08-25 04:46PM
Dec-05-25 11:30AM
09:45AM
Dec-01-25 07:45PM
Nov-25-25 09:50AM
Nov-24-25 09:41PM
Nov-20-25 09:35AM
09:30AM
Nov-19-25 09:45AM
Nov-18-25 04:05PM
05:15AM
Nov-13-25 08:15AM
Oct-31-25 04:05PM
09:45AM
Oct-30-25 01:56PM
Oct-29-25 07:30PM
05:35PM
04:27PM
(Associated Press Finance)
04:05PM
Oct-28-25 01:17PM
(Investor's Business Daily)
Oct-26-25 05:02AM
Oct-23-25 09:39AM
Oct-22-25 10:00AM
Oct-15-25 04:05PM
Oct-14-25 03:28PM
(Investor's Business Daily)
Oct-08-25 09:37AM
Sep-25-25 12:54PM
Sep-24-25 09:45AM
Sep-22-25 02:00AM
Sep-19-25 01:37PM
09:50AM
Sep-17-25 09:40AM
Sep-16-25 09:35AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Weill David Director Sep 11 '26 Buy 81.63 1,336 109,058 16,392 Sep 14 04:30 PM Gunderson Thomas J. Director Jun 15 '26 Option Exercise 2.21 19,285 42,620 26,266 Jun 17 04:15 PM Gunderson Thomas J. Director Jun 15 '26 Sale 75.06 9,624 722,377 16,642 Jun 17 04:15 PM THOMAS GUNDERSON Director Jun 15 '26 Proposed Sale 75.06 9,624 722,403 Jun 15 06:06 PM Lovell Stephanie Director Mar 04 '26 Sale 149.62 1,193 178,497 2,866 Mar 06 06:12 PM Weill David Director Mar 04 '26 Option Exercise 14.20 3,571 50,708 15,705 Mar 06 06:09 PM Weill David Director Mar 04 '26 Sale 146.82 3,571 524,294 12,134 Mar 06 06:09 PM Hernandez Gerardo Chief Financial Officer Mar 04 '26 Option Exercise 71.17 7,236 515,001 20,601 Mar 04 09:40 PM Hernandez Gerardo Chief Financial Officer Mar 04 '26 Sale 147.21 7,236 1,065,212 14,689 Mar 04 09:40 PM Hernandez Gerardo Chief Financial Officer Mar 02 '26 Sale 139.12 375 52,170 14,689 Mar 04 09:40 PM Ranganath Anil P. See remarks Mar 02 '26 Sale 139.12 864 120,200 13,091 Mar 04 08:40 PM Corcoran Nicholas See remarks Mar 02 '26 Sale 139.12 2,966 412,630 29,831 Mar 04 08:40 PM GERARDO P HERNANDEZ Officer Mar 04 '26 Proposed Sale 147.21 7,236 1,065,183 Mar 04 04:34 PM STEPHANIE LOVELL Director Mar 04 '26 Proposed Sale 149.62 1,193 178,491 Mar 04 04:23 PM DAVID WEILL Director Mar 04 '26 Proposed Sale 146.82 3,571 524,295 Mar 04 04:18 PM Weill David Director Dec 03 '25 Option Exercise 14.20 5,000 71,000 17,134 Dec 05 04:30 PM Weill David Director Dec 03 '25 Sale 138.64 5,000 693,200 12,134 Dec 05 04:30 PM Hernandez Gerardo Chief Financial Officer Dec 04 '25 Sale 139.62 920 128,450 15,064 Dec 05 04:30 PM DAVID WEILL Director Dec 03 '25 Proposed Sale 138.64 5,000 693,210 Dec 03 04:06 PM Ranganath Anil P. See remarks Nov 25 '25 Option Exercise 93.88 3,000 281,640 16,955 Nov 26 04:30 PM Ranganath Anil P. See remarks Nov 25 '25 Sale 145.22 3,000 435,660 13,955 Nov 26 04:30 PM ANIL P RANGANATH Officer Nov 25 '25 Proposed Sale 145.22 3,000 435,674 Nov 25 04:11 PM Hassanein Waleed H President & CEO Nov 17 '25 Buy 114.00 8,775 1,000,350 495,009 Nov 18 04:30 PM
TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.
Founder Dr. Waleed H. Hassanein M.D.
Senior Vice President of Supply Chain & Operations Mr. Nicholas Corcoran
Senior Vice President of International Dr. Tamer I. Khayal M.D.
Chief Financial Officer & Treasurer Mr. Fernando Araujo
Senior VP Mr. Matthew Forsyth